Fatty Liver Disease Testing & Awareness Campaign Launches this Summer
The American Liver Foundation announced a screening and public awareness campaign to test for fatty liver disease over the next five years.
Read MorePosted by Andy Lundin | May 24, 2022 | Diabetes & Metabolic Diseases |
The American Liver Foundation announced a screening and public awareness campaign to test for fatty liver disease over the next five years.
Read MorePosted by Chris Wolski | May 20, 2022 | Covid 19, Emerging & Zoonotic Diseases |
A clear set of pandemic prevention and preparedness strategies will be critical for clinical labs to meet the challenges the next event.
Read MorePosted by Andy Lundin | May 17, 2022 | Unknown Origin & Other Cancer Types |
The biomarkers can predict a patient’s response to immunotherapy and the adverse events they may experience from the same immunotherapy.
Read MorePosted by Andy Lundin | May 13, 2022 | Covid 19, Rapid Assays |
Cepheid received FDA EUA for a rapid molecular diagnostic test for qualitative detection of the virus that causes COVID-19.
Read MorePosted by Andy Lundin | May 13, 2022 | Cancer, Molecular Diagnostics |
A new research study showed the PredicineATLAS liquid biopsy next-generation sequencing assay outperforming four other leading assays.
Read More